These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

471 related articles for article (PubMed ID: 33570381)

  • 1. Challenges for Targeting SARS-CoV-2 Proteases as a Therapeutic Strategy for COVID-19.
    Steuten K; Kim H; Widen JC; Babin BM; Onguka O; Lovell S; Bolgi O; Cerikan B; Neufeldt CJ; Cortese M; Muir RK; Bennett JM; Geiss-Friedlander R; Peters C; Bartenschlager R; Bogyo M
    ACS Infect Dis; 2021 Jun; 7(6):1457-1468. PubMed ID: 33570381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MPI8 is Potent against SARS-CoV-2 by Inhibiting Dually and Selectively the SARS-CoV-2 Main Protease and the Host Cathepsin L.
    Ma XR; Alugubelli YR; Ma Y; Vatansever EC; Scott DA; Qiao Y; Yu G; Xu S; Liu WR
    ChemMedChem; 2022 Jan; 17(1):e202100456. PubMed ID: 34242492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ebselen derivatives inhibit SARS-CoV-2 replication by inhibition of its essential proteins: PL
    Zmudzinski M; Rut W; Olech K; Granda J; Giurg M; Burda-Grabowska M; Kaleta R; Zgarbova M; Kasprzyk R; Zhang L; Sun X; Lv Z; Nayak D; Kesik-Brodacka M; Olsen SK; Weber J; Hilgenfeld R; Jemielity J; Drag M
    Sci Rep; 2023 Jun; 13(1):9161. PubMed ID: 37280236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual Inhibitors of Main Protease (M
    Mondal S; Chen Y; Lockbaum GJ; Sen S; Chaudhuri S; Reyes AC; Lee JM; Kaur AN; Sultana N; Cameron MD; Shaffer SA; Schiffer CA; Fitzgerald KA; Thompson PR
    J Am Chem Soc; 2022 Nov; 144(46):21035-21045. PubMed ID: 36356199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mass Spectrometric Assays Reveal Discrepancies in Inhibition Profiles for the SARS-CoV-2 Papain-Like Protease.
    Brewitz L; Kamps JJAG; Lukacik P; Strain-Damerell C; Zhao Y; Tumber A; Malla TR; Orville AM; Walsh MA; Schofield CJ
    ChemMedChem; 2022 May; 17(9):e202200016. PubMed ID: 35085423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-based design of SARS-CoV-2 papain-like protease inhibitors.
    Jadhav P; Huang B; Osipiuk J; Zhang X; Tan H; Tesar C; Endres M; Jedrzejczak R; Tan B; Deng X; Joachimiak A; Cai J; Wang J
    Eur J Med Chem; 2024 Jan; 264():116011. PubMed ID: 38065031
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Tronco Pauletto PJ; Omage FB; Delgado CP; Nogara PA; Teixeira Rocha JB
    Curr Drug Discov Technol; 2023; 20(2):e101022209771. PubMed ID: 36221883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compounds derived from Humulus lupulus inhibit SARS-CoV-2 papain-like protease and virus replication.
    Herzog AM; Göbel K; Marongiu L; Ruetalo N; Alonso MC; Leischner C; Busch C; Burkard M; Lauer UM; Geurink PP; Knobeloch KP; Schindler M; Fritz G; Venturelli S
    Phytomedicine; 2024 Jan; 123():155176. PubMed ID: 37976697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diphenyl Diselenide and SARS-CoV-2:
    Omage FB; Madabeni A; Tucci AR; Nogara PA; Bortoli M; Rosa ADS; Neuza Dos Santos Ferreira V; Teixeira Rocha JB; Miranda MD; Orian L
    J Chem Inf Model; 2023 Apr; 63(7):2226-2239. PubMed ID: 36952618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-Based Design of a Dual-Targeted Covalent Inhibitor Against Papain-like and Main Proteases of SARS-CoV-2.
    Yu W; Zhao Y; Ye H; Wu N; Liao Y; Chen N; Li Z; Wan N; Hao H; Yan H; Xiao Y; Lai M
    J Med Chem; 2022 Dec; 65(24):16252-16267. PubMed ID: 36503248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-throughput screening of SARS-CoV-2 main and papain-like protease inhibitors.
    Zang Y; Su M; Wang Q; Cheng X; Zhang W; Zhao Y; Chen T; Jiang Y; Shen Q; Du J; Tan Q; Wang P; Gao L; Jin Z; Zhang M; Li C; Zhu Y; Feng B; Tang B; Xie H; Wang MW; Zheng M; Pan X; Yang H; Xu Y; Wu B; Zhang L; Rao Z; Yang X; Jiang H; Xiao G; Zhao Q; Li J
    Protein Cell; 2023 Jan; 14(1):17-27. PubMed ID: 36726755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of small molecules with the SARS-CoV-2 papain-like protease: In silico studies and in vitro validation of protease activity inhibition using an enzymatic inhibition assay.
    Pitsillou E; Liang J; Ververis K; Hung A; Karagiannis TC
    J Mol Graph Model; 2021 May; 104():107851. PubMed ID: 33556646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of Novel Small-Molecule Inhibitors of SARS-CoV-2 Main Protease as Potential Leads for COVID-19 Treatment.
    Manandhar A; Srinivasulu V; Hamad M; Tarazi H; Omar H; Colussi DJ; Gordon J; Childers W; Klein ML; Al-Tel TH; Abou-Gharbia M; Elokely KM
    J Chem Inf Model; 2021 Sep; 61(9):4745-4757. PubMed ID: 34403259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Azapeptides with unique covalent warheads as SARS-CoV-2 main protease inhibitors.
    Khatua K; Alugubelli YR; Yang KS; Vulupala VR; Blankenship LR; Coleman D; Atla S; Chaki SP; Geng ZZ; Ma XR; Xiao J; Chen PH; Cho CD; Sharma S; Vatansever EC; Ma Y; Yu G; Neuman BW; Xu S; Liu WR
    Antiviral Res; 2024 May; 225():105874. PubMed ID: 38555023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Patent Review on SARS Coronavirus Papain-Like Protease (PL
    Brian Chia CS; Pheng Lim S
    ChemMedChem; 2023 Aug; 18(16):e202300216. PubMed ID: 37248169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-Based Design of Potent Peptidomimetic Inhibitors Covalently Targeting SARS-CoV-2 Papain-like Protease.
    Wang Q; Chen G; He J; Li J; Xiong M; Su H; Li M; Hu H; Xu Y
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37239980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting Viral and Cellular Cysteine Proteases for Treatment of New Variants of SARS-CoV-2.
    Gentile D; Chiummiento L; Santarsiere A; Funicello M; Lupattelli P; Rescifina A; Venuti A; Piperno A; Sciortino MT; Pennisi R
    Viruses; 2024 Feb; 16(3):. PubMed ID: 38543704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Cysteine 270 as a Novel Site for Allosteric Modulators of SARS-CoV-2 Papain-Like Protease.
    Hu H; Wang Q; Su H; Shao Q; Zhao W; Chen G; Li M; Xu Y
    Angew Chem Int Ed Engl; 2022 Dec; 61(52):e202212378. PubMed ID: 36308706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Aloe-derived natural products as prospective lead scaffolds for SARS-CoV-2 main protease (M
    Hicks EG; Kandel SE; Lampe JN
    Bioorg Med Chem Lett; 2022 Jun; 66():128732. PubMed ID: 35427739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Olgotrelvir, a dual inhibitor of SARS-CoV-2 M
    Mao L; Shaabani N; Zhang X; Jin C; Xu W; Argent C; Kushnareva Y; Powers C; Stegman K; Liu J; Xie H; Xu C; Bao Y; Xu L; Zhang Y; Yang H; Qian S; Hu Y; Shao J; Zhang C; Li T; Li Y; Liu N; Lin Z; Wang S; Wang C; Shen W; Lin Y; Shu D; Zhu Z; Kotoi O; Kerwin L; Han Q; Chumakova L; Teijaro J; Royal M; Brunswick M; Allen R; Ji H; Lu H; Xu X
    Med; 2024 Jan; 5(1):42-61.e23. PubMed ID: 38181791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.